SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-20-037182
Filing Date
2020-02-14
Accepted
2020-02-14 11:02:06
Documents
3
Group Members
ANNE-MARI PASTERCLAUDIO NESSIOMEGA FUND IV GP MANAGER, LTD.OMEGA FUND IV GP, L.P.OMEGA FUND V GP MANAGER, LTD.OMEGA FUND V GP, L.P.OMEGA FUND V, L.P.OTELLO STAMPACCHIA

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d866387dsc13ga.htm SC 13G/A 192499
2 EX-99.1 d866387dex991.htm EX-99.1 12598
3 EX-99.2 d866387dex992.htm EX-99.2 11487
  Complete submission text file 0001193125-20-037182.txt   218438
Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund IV, L.P. (Filed by) CIK: 0001528382 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Subject) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90547 | Film No.: 20615652
SIC: 2836 Biological Products, (No Diagnostic Substances)